drugset
drugset / Trial / NCT02544529

Echothiophate Iodide for the Prevention of Progression of Myopia

NCT02544529 ↗

Phase 4 Withdrawn Danbury Eye Physicians & Surgeons, PC
RandomizedSingle-groupTriple-blindPrevention

Summary

The purpose of this study is to test the hypothesis that myopia progression can be slowed or prevented by low dose Echothiophate Iodide.

Timeline

Start
2016-06-01
Primary completion
2016-06-01
Completion
2016-06-01

Outcome

Outcome not reported

Stopped (Business): “No funding available”

Drugs

EvaluationDrugModalityDoseRoute
Subject ECHOTHIOPHATE Small molecule 0.03 % Other

Indications

myopia